Prediction of drug-drug interaction risk of P-glycoprotein substrate in drug discovery
- 11 March 2024
- journal article
- research article
- Published by Elsevier in Drug Metabolism and Pharmacokinetics
- Vol. 56, 101008
Abstract
No abstract availableKeywords
Funding Information
- Shionogi
This publication has 29 references indexed in Scilit:
- Carboxylesterase-2 plays a critical role in dabigatran etexilate active metabolite formationDrug Metabolism and Pharmacokinetics, 2022
- Species difference in brain penetration of P-gp and BCRP substrates among monkey, dog and mouseDrug Metabolism and Pharmacokinetics, 2022
- Physicochemical Properties, Biotransformation, and Transport Pathways of Established and Newly Approved Medications: A Systematic Review of the Top 200 Most Prescribed Drugs vs. the FDA-Approved Drugs Between 2005 and 2016Clinical Pharmacokinetics, 2019
- Old and new oral anticoagulants: Food, herbal medicines and drug interactionsBlood Reviews, 2017
- Quantitative Targeted Absolute Proteomics of Transporters and Pharmacoproteomics-Based Reconstruction of P-Glycoprotein Function in Mouse Small IntestineMolecular Pharmaceutics, 2016
- Exploring new gene integration sites for gene knock-in by gene-trapping strategyTransgenic Research, 2015
- Using Improved Serial Blood Sampling Method of Mice to Study Pharmacokinetics and Drug–Drug InteractionJournal of Pharmaceutical Sciences, 2015
- Effects of the inhibition of intestinal P‐glycoprotein on aliskiren pharmacokinetics in cynomolgus monkeysBiopharmaceutics & Drug Disposition, 2014
- Prediction of Nonlinear Intestinal Absorption of CYP3A4 and P-Glycoprotein Substrates from their In Vitro Km ValuesPharmaceutical Research, 2011
- Active secretion and enterocytic drug metabolism barriers to drug absorption1PII of original article: S0169-409X(96)003304. The article was originally published in Advanced Drug Delivery Reviews 20 (1996) 99–112.1Advanced Drug Delivery Reviews, 2001